vs
Side-by-side financial comparison of Ladder Capital Corp (LADR) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $22.3M, roughly 1.4× Ladder Capital Corp). Ladder Capital Corp runs the higher net margin — 71.0% vs -32.1%, a 103.2% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -18.0%). Ladder Capital Corp produced more free cash flow last quarter ($78.7M vs $25.0K). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -22.5%).
Ladder Capital Corp is a leading commercial real estate finance firm operating primarily across the United States. It originates and manages a diversified portfolio of senior secured commercial mortgage loans, mezzanine debt, commercial mortgage-backed securities, and direct real estate assets, serving property owners, operators and developers across major market segments.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
LADR vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $22.3M | $31.1M |
| Net Profit | $15.9M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | 69.5% | -9.9% |
| Net Margin | 71.0% | -32.1% |
| Revenue YoY | -18.0% | -4.5% |
| Net Profit YoY | -49.4% | -52.0% |
| EPS (diluted) | $0.13 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.3M | — | ||
| Q3 25 | $27.8M | $31.1M | ||
| Q2 25 | $21.5M | — | ||
| Q1 25 | $20.3M | $35.2M | ||
| Q4 24 | $27.2M | $32.6M | ||
| Q3 24 | $38.4M | $24.7M | ||
| Q2 24 | $34.3M | — | ||
| Q1 24 | $37.1M | $35.7M |
| Q4 25 | $15.9M | — | ||
| Q3 25 | $19.2M | $-10.0M | ||
| Q2 25 | $17.1M | — | ||
| Q1 25 | $11.6M | $-14.8M | ||
| Q4 24 | $31.3M | $-6.6M | ||
| Q3 24 | $27.6M | $-16.2M | ||
| Q2 24 | $32.1M | — | ||
| Q1 24 | $16.4M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | 69.5% | — | ||
| Q3 25 | 72.4% | -9.9% | ||
| Q2 25 | 96.7% | — | ||
| Q1 25 | 52.7% | -25.7% | ||
| Q4 24 | — | -6.0% | ||
| Q3 24 | 74.1% | -46.9% | ||
| Q2 24 | 90.4% | — | ||
| Q1 24 | 49.4% | -2.5% |
| Q4 25 | 71.0% | — | ||
| Q3 25 | 69.0% | -32.1% | ||
| Q2 25 | 79.5% | — | ||
| Q1 25 | 56.8% | -42.0% | ||
| Q4 24 | 115.1% | -20.2% | ||
| Q3 24 | 71.7% | -65.7% | ||
| Q2 24 | 93.6% | — | ||
| Q1 24 | 44.2% | 43.8% |
| Q4 25 | $0.13 | — | ||
| Q3 25 | $0.15 | $-0.29 | ||
| Q2 25 | $0.14 | — | ||
| Q1 25 | $0.09 | $-0.47 | ||
| Q4 24 | $0.25 | $-0.25 | ||
| Q3 24 | $0.22 | $-0.53 | ||
| Q2 24 | $0.26 | — | ||
| Q1 24 | $0.13 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $38.0M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $1.5B | $-10.5M |
| Total Assets | $5.2B | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.0M | — | ||
| Q3 25 | $49.4M | $18.9M | ||
| Q2 25 | $134.9M | — | ||
| Q1 25 | $479.8M | $5.4M | ||
| Q4 24 | $1.3B | $9.5M | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | $-10.5M | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | $2.2M | ||
| Q4 24 | $1.5B | $15.4M | ||
| Q3 24 | $1.5B | $-3.9M | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | $17.7M |
| Q4 25 | $5.2B | — | ||
| Q3 25 | $4.7B | $235.2M | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | $237.7M | ||
| Q4 24 | $4.8B | $255.4M | ||
| Q3 24 | $4.8B | $246.8M | ||
| Q2 24 | $4.8B | — | ||
| Q1 24 | $5.3B | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.0M | $1.8M |
| Free Cash FlowOCF − Capex | $78.7M | $25.0K |
| FCF MarginFCF / Revenue | 352.4% | 0.1% |
| Capex IntensityCapex / Revenue | 37.4% | 5.6% |
| Cash ConversionOCF / Net Profit | 5.49× | — |
| TTM Free Cash FlowTrailing 4 quarters | $118.3M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.0M | — | ||
| Q3 25 | $26.3M | $1.8M | ||
| Q2 25 | $44.0M | — | ||
| Q1 25 | $-28.7M | $1.2M | ||
| Q4 24 | $133.9M | $-6.1M | ||
| Q3 24 | $169.0M | $-613.0K | ||
| Q2 24 | $45.4M | — | ||
| Q1 24 | $-20.4M | $-1.4M |
| Q4 25 | $78.7M | — | ||
| Q3 25 | $25.9M | $25.0K | ||
| Q2 25 | $43.4M | — | ||
| Q1 25 | $-29.6M | $-4.3M | ||
| Q4 24 | $127.4M | $-8.6M | ||
| Q3 24 | $166.0M | $-4.0M | ||
| Q2 24 | $44.9M | — | ||
| Q1 24 | $-21.7M | $-7.8M |
| Q4 25 | 352.4% | — | ||
| Q3 25 | 93.1% | 0.1% | ||
| Q2 25 | 201.6% | — | ||
| Q1 25 | -145.6% | -12.1% | ||
| Q4 24 | 468.2% | -26.3% | ||
| Q3 24 | 432.1% | -16.3% | ||
| Q2 24 | 131.0% | — | ||
| Q1 24 | -58.6% | -21.8% |
| Q4 25 | 37.4% | — | ||
| Q3 25 | 1.7% | 5.6% | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 4.3% | 15.5% | ||
| Q4 24 | 23.9% | 7.5% | ||
| Q3 24 | 7.8% | 13.9% | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 3.7% | 17.8% |
| Q4 25 | 5.49× | — | ||
| Q3 25 | 1.37× | — | ||
| Q2 25 | 2.57× | — | ||
| Q1 25 | -2.49× | — | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | 6.13× | — | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | -1.24× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LADR
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
